This invention relates to an intervertebral motion disc having an articulation interface and a locking interface.
The present invention relates to administering autologous uncultured cells into a diseased intervertebral disc.
The present invention relates to trans-capsularly administering into a diseased joint a high specificity antagonist selected from the group consisting of: i) an inhibitor of a pro-inflammatory interleukin; ii) an inhibitor of TNF-α synthesis; iii) an inhibitor of membrane-bound TNF-α; iv) an inhibit ...
The present invention relates to administering autologous uncultured cells into a diseased intervertebral disc.
This invention relates to local administration of a bone-forming agent and at least one anti-resorptive agent to treat osteoporosis and related disorders.
The present invention relates to administering autologous uncultured cells into a diseased intervertebral disc.
The present invention relates to injecting a high specificity p38 kinase inhibitor into a diseased intervertebral disc.
The present invention relates to injecting a high affinity antagonist of MMPs into a diseased intervertebral disc.
The present invention relates to trans-capsularly administering into a diseased joint a high specificity antagonist selected from the group consisting of: i) an inhibitor of a pro-inflammatory interleukin; ii) an inhibitor of TNF-α synthesis; iii) an inhibitor of membrane-bound TNF-α; iv) an inhibit ...
The present invention relates to injecting a cycline compound into a diseased intervertebral disc.